Abstract: The present disclosure provides compositions and methods for dispersion of CNTs using a CNT solvent comprising an aromatic ring structure including at least one sulfonic acid functional group. Alternatively, the aromatic ring structure further includes at least a linear or branched alkyl chain. Examples of the carbon nanotube solvent includes dodecyl benzene sulfonic acid.

Abstract: A polymerization process includes contacting an ethylene feed containing ethylene monomers with a catalyst feed containing a hafnium-based or zirconium-based single-site catalyst in a solution so as to polymerize the ethylene monomers into long-chain branched high density polyethylene having on average a long-chain branch/polymer chain less than 10 and greater than 0.25. A polymerization composition includes ethylene; a hafnium-based or zirconium-based single-site catalyst; and a long-chain branched high density polyethylene polymerization product, where the long-chain branched high density polyethylene has on average a long-chain branch/polymer chain less than 10 and greater than 0.25; and where at least one of the ethylene, the catalyst, and the product is in solution.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: Methods, systems, and devices for wireless communication are described. A wireless device may initiate a successive decoding process for an encoded code block received at the wireless device, and generate, using a successive decoder, one or more candidate paths for a first portion of the code block, where the first portion of the code block includes a first data portion and a first data check portion. The wireless device may then perform a checking function on respective first data portions for the one or more candidate paths using respective first data check portions, and determine whether to terminate the successive decoding process prior to completing decoding of the encoded code block based at least in part on determining whether the checking function for each of the one or more candidate paths for the first data portion has failed the checking function.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: Disclosed embodiments concern a device for administering a xinafoate salt of N4-[(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy)phenyl]-2,4-pyrimidinediamine, or compositions thereof, and a method for making and using the device. Particular disclosed embodiments concern formulating the xinafoate salt for administration via the device.

Abstract: Methods, systems, and devices for wireless communication are described. A wireless device may initiate a successive decoding process for an encoded code block received at the wireless device, and generate, using a successive decoder, one or more candidate paths for a first portion of the code block, where the first portion of the code block includes a first data portion and a first data check portion. The wireless device may then perform a checking function on respective first data portions for the one or more candidate paths using respective first data check portions, and determine whether to terminate the successive decoding process prior to completing decoding of the encoded code block based at least in part on determining whether the checking function for each of the one or more candidate paths for the first data portion has failed the checking function.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: Provided are blends of branched hydrocarbon comb polymers having tailored branching and molecular weight parameters, with substantially linear polymers. Such blends have been found to have improved extensional rheological properties, while maintaining nearly the viscosity of the substantially linear polymers. The blends of the hydrocarbon comb polymers with the substantially linear polymers thus maintain the extrusion processing characteristics of the linear polymer alone, but have improved extensional flow processability, with strain hardening ratios (SHR) greater than 1. The blends are effective in blown film processing. Also disclosed are related methods for improving extensional flow processability using the branched hydrocarbon comb polymers, as well as the branched hydrocarbon comb polymers themselves, including as a property enhancing additive for such substantially linear polymers.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Abstract: Embodiments of topical formulations for administering compound I or a pharmaceutically acceptable salt or solvate thereof are disclosed. Embodiments of methods for using the topical formulations in the treatment of dermatological disorders such as cutaneous collagen vascular diseases, e.g., cutaneous lupus, also are disclosed.

Abstract: The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.